Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126798282 | 12679828 | 2 | F | 20160530 | 20160819 | 20160824 | 20160901 | EXP | GB-TEVA-684915ACC | TEVA | 71.00 | YR | M | Y | 0.00000 | 20160901 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126798282 | 12679828 | 1 | PS | DILTIAZEM. | DILTIAZEM | 1 | Unknown | 180 MILLIGRAM DAILY; 180 MG, UNK | U | U | 74067 | 180 | MG | QD | |||||
| 126798282 | 12679828 | 2 | SS | GLICLAZIDE | GLICLAZIDE | 1 | Unknown | 80 MILLIGRAM DAILY; 80 MG, QD | U | U | 0 | 80 | MG | QD | |||||
| 126798282 | 12679828 | 3 | SS | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | Unknown | 30 MILLIGRAM DAILY; 30 MG, QD | U | U | 77255 | 30 | MG | QD | |||||
| 126798282 | 12679828 | 4 | SS | METFORMIN HYDROCHLORIDE. | METFORMIN HYDROCHLORIDE | 1 | Unknown | U | U | 75975 | TABLET | ||||||||
| 126798282 | 12679828 | 5 | SS | PRAVASTATIN. | PRAVASTATIN | 1 | Unknown | 20 MILLIGRAM DAILY; 20 MG, QD | U | U | 76056 | 20 | MG | QD | |||||
| 126798282 | 12679828 | 6 | SS | SALBUTAMOL | ALBUTEROL | 1 | Unknown | 5 MILLIGRAM DAILY; 5 MG, QD | U | U | 0 | 5 | MG | QD | |||||
| 126798282 | 12679828 | 7 | SS | FERROUS SULFATE. | FERROUS SULFATE | 1 | Unknown | U | U | 0 | |||||||||
| 126798282 | 12679828 | 8 | SS | FOSTAIR | BECLOMETHASONEFORMOTEROL | 1 | Unknown | 4 DF, UNK | U | U | 0 | 4 | DF | ||||||
| 126798282 | 12679828 | 9 | SS | CARBOCISTEINE | CARBOCYSTEINE | 1 | Unknown | 750 MILLIGRAM DAILY; 750 MG, QD | U | U | 0 | 750 | MG | QD | |||||
| 126798282 | 12679828 | 10 | SS | IPRATROPIUM | IPRATROPIUM | 1 | Unknown | 500 MILLIGRAM DAILY; 500 MG, QD | U | U | 0 | 500 | MG | QD | |||||
| 126798282 | 12679828 | 11 | SS | ITRACONAZOLE. | ITRACONAZOLE | 1 | Unknown | 200 MILLIGRAM DAILY; 200 MG, QD | U | U | 0 | 200 | MG | QD | |||||
| 126798282 | 12679828 | 12 | SS | LINAGLIPTIN | LINAGLIPTIN | 1 | Unknown | 5 MILLIGRAM DAILY; 5 MG, QD | U | U | 0 | 5 | MG | QD | |||||
| 126798282 | 12679828 | 13 | SS | PARACETAMOL | ACETAMINOPHEN | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 126798282 | 12679828 | 14 | SS | TAMSULOSIN | TAMSULOSIN | 1 | Unknown | 400 MILLIGRAM DAILY; 400 MG, QD | U | U | 0 | 400 | MG | QD | |||||
| 126798282 | 12679828 | 15 | SS | TAZOCIN | PIPERACILLIN SODIUMTAZOBACTAM SODIUM | 1 | U | U | 0 | ||||||||||
| 126798282 | 12679828 | 16 | SS | TAZOCIN | PIPERACILLIN SODIUMTAZOBACTAM SODIUM | 1 | Intravenous (not otherwise specified) | 13.5 GRAM DAILY; 13.5 G, QD | U | U | 0 | 13.5 | G | QD | |||||
| 126798282 | 12679828 | 17 | SS | TAZOCIN | PIPERACILLIN SODIUMTAZOBACTAM SODIUM | 1 | U | U | 0 | ||||||||||
| 126798282 | 12679828 | 18 | SS | TIOTROPIUM | TIOTROPIUM | 1 | Unknown | 18 MICROGRAM DAILY; 18 ?G, UNK | U | U | 0 | 18 | UG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126798282 | 12679828 | 1 | Product used for unknown indication |
| 126798282 | 12679828 | 2 | Product used for unknown indication |
| 126798282 | 12679828 | 3 | Product used for unknown indication |
| 126798282 | 12679828 | 4 | Product used for unknown indication |
| 126798282 | 12679828 | 5 | Product used for unknown indication |
| 126798282 | 12679828 | 6 | Product used for unknown indication |
| 126798282 | 12679828 | 7 | Product used for unknown indication |
| 126798282 | 12679828 | 8 | Product used for unknown indication |
| 126798282 | 12679828 | 9 | Product used for unknown indication |
| 126798282 | 12679828 | 10 | Product used for unknown indication |
| 126798282 | 12679828 | 11 | Product used for unknown indication |
| 126798282 | 12679828 | 12 | Product used for unknown indication |
| 126798282 | 12679828 | 13 | Product used for unknown indication |
| 126798282 | 12679828 | 14 | Product used for unknown indication |
| 126798282 | 12679828 | 15 | Chronic obstructive pulmonary disease |
| 126798282 | 12679828 | 16 | Lower respiratory tract infection |
| 126798282 | 12679828 | 17 | Respiratory failure |
| 126798282 | 12679828 | 18 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126798282 | 12679828 | HO |
| 126798282 | 12679828 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126798282 | 12679828 | Condition aggravated | |
| 126798282 | 12679828 | Dyspnoea | |
| 126798282 | 12679828 | Oxygen saturation decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |